Objects
Lees, Kennedy R., Bluhmki, Erich, Tilley, Barbara C., Davis, Stephen M., Donnan, Geoffrey A., Hacke, Werner, ECASS, ATLANTIS, NINDS, and EPITHET rt-PA Study Groups, Allen, K., Mau, J., Meier, D., Del Zoppo, G., De Silva, D. A., von Kummer, Rudiger, Butcher, K. S., Parsons, M. W., Barber, P. A., Levi, C., Bladin, C., Byrnes, G., Brott, Thomas G., Toni, Danilo, Grotta, James C., Albers, Gregory W., Kaste, Markku, Marler, John R., Hamilton, Scott A.. Elsevier; 2010. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Anderson, C. S., Robinson, T., Kim, J. S., Thang, N. H., Cao, Y., Parsons, M. W., Levi, C., Huang, Y., Olavarría, V. V., Demchuk, A. M., Bath, P. M., Donnan, G. A., Lindley, R. I., Arima, H., Lavados, P. M., Lee, T. - H., Broderick, J. P., Chen, X., Chen, G., Sharma, V. K.. Massachusetts Medical Society; 2016. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke.